The inspector general at the U.S. Department of Health and Human Services could launch an inquiry into the scientist, UT child pharmacology researcher Karen Wagner. Iowa Sen. Charles Grassley, the ranking member of the Senate Finance Committee, sent a letter to the University of Texas System in September raising concerns that Karen Wagner had not properly disclosed her financial connections with drug companies.
Read article in the Dallas Morning News (USA)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment